{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:16:39Z","timestamp":1790975799394,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s13760-023-02190-5","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T10:03:52Z","timestamp":1677837832000},"page":"1039-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study"],"prefix":"10.1007","volume":"123","author":[{"given":"Simona","family":"Guerzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8432-1888","authenticated-orcid":false,"given":"Carlo","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Brovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Michela","family":"Cainazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Lo","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"2190_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"2190_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1177\/0333102409355601","volume":"30","author":"TW Victor","year":"2010","unstructured":"Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB (2010) Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 30:1065\u20131072. https:\/\/doi.org\/10.1177\/0333102409355601","journal-title":"Cephalalgia"},{"key":"2190_CR3","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67:2154\u20132158. https:\/\/doi.org\/10.1212\/01.wnl.0000233888.18228.19","journal-title":"Neurology"},{"key":"2190_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13643-021-01618-4","volume":"10","author":"N Reddy","year":"2021","unstructured":"Reddy N, Desai MN, Schoenbrunner A, Schneeberger S, Janis JE (2021) The complex relationship between estrogen and migraines: a scoping review. Syst Rev 10:72. https:\/\/doi.org\/10.1186\/s13643-021-01618-4","journal-title":"Syst Rev"},{"key":"2190_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/head.12763","volume":"56","author":"VT Martin","year":"2016","unstructured":"Martin VT, Pavlovic J, Fanning KM, Buse DC, Reed ML, Lipton RB (2016) Perimenopause and menopause are associated with high frequency headache in women with migraine: results of the American migraine prevalence and prevention study. Headache 56:292\u2013305. https:\/\/doi.org\/10.1111\/head.12763","journal-title":"Headache"},{"key":"2190_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0333102416653234","volume":"37","author":"K Makita","year":"2017","unstructured":"Makita K, Inagaki M, Kitamura S, Tatsuoka Y (2017) Changes in migraine before and after menopause in Japanese climacteric women. Cephalalgia 37:1088\u20131092. https:\/\/doi.org\/10.1177\/0333102416653234","journal-title":"Cephalalgia"},{"key":"2190_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000336838","volume":"68","author":"K Oh","year":"2012","unstructured":"Oh K, Jung KY, Choi JY, Seo WK, Park KW (2012) Headaches in middle-aged women during menopausal transition: a headache clinic-based study. Eur Neurol 68:79\u201383. https:\/\/doi.org\/10.1159\/000336838","journal-title":"Eur Neurol"},{"key":"2190_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2147\/IJWH.S70073","volume":"7","author":"P Ripa","year":"2015","unstructured":"Ripa P, Ornello R, Degan D, Tiseo C, Stewart J, Pistoia F, Carolei A, Sacco S (2015) Migraine in menopausal women: a systematic review. Int J Womens Health 7:773\u2013782. https:\/\/doi.org\/10.2147\/IJWH.S70073","journal-title":"Int J Womens Health"},{"key":"2190_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","volume":"45","author":"SN Ozyalcin","year":"2005","unstructured":"Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R (2005) The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 45:144\u2013152. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.05029.x","journal-title":"Headache"},{"key":"2190_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3988\/jcn.2006.2.4.246","volume":"2","author":"HJ Park","year":"2006","unstructured":"Park HJ, Lee ST, Shim JY, Kim B, Hwang SH, Kim SH, Park JE, Park JH, Jung SH, Ahn JY, Chu K, Kim M (2006) The effect of paroxetine on the reduction of migraine frequency is independent of its anxiolytic effect. J Clin Neurol 2:246\u2013251. https:\/\/doi.org\/10.3988\/jcn.2006.2.4.246","journal-title":"J Clin Neurol"},{"key":"2190_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.2010.2016","volume":"305","author":"EW Freeman","year":"2011","unstructured":"Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE, Reed SD, Newton KM, Sherman S, Sammel MD, LaCroix AZ (2011) Efficacy of escitalopram for hot flashes in healthy menopausal woman: a randomized controlled trial. JAMA 305:267\u2013274. https:\/\/doi.org\/10.1001\/jama.2010.2016","journal-title":"JAMA"},{"key":"2190_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010609","author":"M Linde","year":"2013","unstructured":"Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013) Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010609","journal-title":"Cochrane Database Syst Rev"},{"key":"2190_CR13","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1056\/NEJMp1402080","volume":"370","author":"RJ Orleans","year":"2014","unstructured":"Orleans RJ, Li L, Kim MJ, Guo J, Sobhan M, Soule L, Joffe HV (2014) FDA approval of paroxetine for menopausal hot flushes. N Engl J Med 370:1777\u20131779. https:\/\/doi.org\/10.1056\/NEJMp1402080","journal-title":"N Engl J Med"},{"key":"2190_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1258\/mi.2009.009022","volume":"15","author":"R Nappi","year":"2009","unstructured":"Nappi R, Sances G, Detaddei S, Ornati A, Chiovato L, Polatti F (2009) Hormonal management of migraine at menopause. Menopause Int 15:82\u201386. https:\/\/doi.org\/10.1258\/mi.2009.009022","journal-title":"Menopause Int"},{"key":"2190_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10194-019-1013-0","volume":"20","author":"TP Do","year":"2019","unstructured":"Do TP, Guo S, Ashina M (2019) Therapeutic novelties in migraine: new drugs, new hope? J Headache Pain 20:37. https:\/\/doi.org\/10.1186\/s10194-019-1013-0","journal-title":"J Headache Pain"},{"key":"2190_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/0333102410379890","volume":"31","author":"M Yang","year":"2011","unstructured":"Yang M, Rendas-Baum R, Varon SF, Kosinski M (2011) Validation of the headache impact test (HIT-6\u2122) across episodic and chronic migraine. Cephalalgia 31:357\u2013367. https:\/\/doi.org\/10.1177\/0333102410379890","journal-title":"Cephalalgia"},{"key":"2190_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s10194-018-0837-3","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ, Lipton RB, Lifting The Burden: The Global Campaign against Headache (2018) The headache-attributed lost time (HALT) indices: measures of burden for clinical management and population-based research. J Headache Pain 19:12. https:\/\/doi.org\/10.1186\/s10194-018-0837-3","journal-title":"J Headache Pain"},{"key":"2190_CR18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1046\/j.0333-1024.2001.00277.x","volume":"21","author":"D D\u2019Amico","year":"2001","unstructured":"D\u2019Amico D, Mosconi P, Genco S, Usai S, Prudenzano AM, Grazzi L, Leone M, Puca FM, Bussone G (2001) The migraine disability assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 21:947\u2013952. https:\/\/doi.org\/10.1046\/j.0333-1024.2001.00277.x","journal-title":"Cephalalgia"},{"key":"2190_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/164_2018_201","volume":"255","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson L (2019) Role of CGRP in migraine. Hand Exp Pharmacol 255:121\u2013130. https:\/\/doi.org\/10.1007\/164_2018_201","journal-title":"Hand Exp Pharmacol"},{"key":"2190_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/ob.1996.v175.a74287","volume":"175","author":"A Valentini","year":"1996","unstructured":"Valentini A, Petraglia F, De Vita D, Nappi C, Margutti A, degli Uberti EC, Genazzani AR (1996) Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. Am J Obstet Gynecol 175:638\u2013642. https:\/\/doi.org\/10.1053\/ob.1996.v175.a74287","journal-title":"Am J Obstet Gynecol"},{"key":"2190_CR21","doi-asserted-by":"publisher","first-page":"871176","DOI":"10.3389\/fneur.2022.871176","volume":"13","author":"L Pellesi","year":"2022","unstructured":"Pellesi L, Al-Karagholi MAM, De Icco R, Chaudhry BA, Lopez CL, Snellman J, Hannibal J, Amin FM, Ashina M (2022) Plasma levels of CGRP during a 2-h infusion of VIP in healthy volunteers and patients with migraine: an exploratory study. Front Neurol 13:871176. https:\/\/doi.org\/10.3389\/fneur.2022.871176","journal-title":"Front Neurol"},{"key":"2190_CR22","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1093\/brain\/awac040","volume":"145","author":"C Ernstsen","year":"2022","unstructured":"Ernstsen C, Christensen SL, Rasmussen RH, Nielsen BS, Jansen-Olesen I, Olesen J, Kristenson DM (2022) The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target? Brain 145:2450\u20132460. https:\/\/doi.org\/10.1093\/brain\/awac040","journal-title":"Brain"},{"key":"2190_CR23","doi-asserted-by":"publisher","first-page":"e2488","DOI":"10.1212\/WNL0000000000011930","volume":"96","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Kaaragholi MAM, Arngrim N, M\u00f8rch-Rasmussen M, Walker CS, Hay DL, Ashina M (2021) Effect of adrenomedullin on migraine-like attacks in patients with migraine: a randomized crossover study. Neurology 96:e2488\u2013e2499. https:\/\/doi.org\/10.1212\/WNL0000000000011930","journal-title":"Neurology"},{"key":"2190_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/ana.26072","volume":"89","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Karagholi MAM, Walker CS, Arngrim N, Rees T, Petersen J, Siow A, M\u00f8rch-Rasmussen M, Tan S, O\u2019Carroll SJ, Harris P, Skovgaard LT, J\u00f8rgensen NR, Brimble M, Waite JS, Rea BJ, Sowers LP, Russo AF, Hay DL, Ashina M (2021) Amylin analog pramlintide induces migraine-like attacks in patients. Ann Neurol 89:1157\u20131171. https:\/\/doi.org\/10.1002\/ana.26072","journal-title":"Ann Neurol"},{"key":"2190_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/WCO.000000000001053","volume":"35","author":"B Tesfay","year":"2022","unstructured":"Tesfay B, Karlsson WK, Moreno RD, Hay DL, Hougaard A (2022) Is calcitonin gene-related peptide a reliable biochemical marker of migraine? Curr Opin Neurol 35:343\u2013352. https:\/\/doi.org\/10.1097\/WCO.000000000001053","journal-title":"Curr Opin Neurol"},{"key":"2190_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0333102417739584","volume":"39","author":"A Labastida-Ram\u00ecrez","year":"2019","unstructured":"Labastida-Ram\u00ecrez A, Rubio-Beltr\u00e0n E, Villal\u00f2n CM, MaassenVanDenBrink A (2019) Gender aspects of CGRP in migraine. Cephalalgia 39:435\u2013444","journal-title":"Cephalalgia"},{"key":"2190_CR27","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1136\/bmj.293.6558.1329","volume":"293","author":"JC Stevenson","year":"1986","unstructured":"Stevenson JC, Macdonald DW, Warren RC, Booker MW, Whitehead MI (1986) Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. Br Med J (Clin Res Ed) 293:1329\u20131330. https:\/\/doi.org\/10.1136\/bmj.293.6558.1329","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2190_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s10194-020-01197-0","volume":"21","author":"K Warfringe","year":"2020","unstructured":"Warfringe K, Krause DN, Maddahi A, Edvinsson JCA, Edvinsson L, Haanes KA (2020) Estrogen receptors \u03b1, \u03b2 and GPER in the CNS and trigeminal system-molecular and functional aspects. J Headache Pain 21:131. https:\/\/doi.org\/10.1186\/s10194-020-01197-0","journal-title":"J Headache Pain"},{"key":"2190_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/WNL.0000000000001142","volume":"84","author":"K Ibrahimi","year":"2015","unstructured":"Ibrahimi K, van Oosterhout WPJ, Van Dorp W, Danser AHJ, Garrelds IM, Kushner SA, Lesaffre EMEH, Terwindt GM, Ferrari MD, van der Meiracker AH, MaassenVanDenBrink A (2015) Reduced trigeminovascular cyclicity in patients with menstrually related migraine. Neurology 84:125\u2013131","journal-title":"Neurology"},{"key":"2190_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2053369117731172","volume":"24","author":"EA MacGregor","year":"2018","unstructured":"MacGregor EA (2018) Migraine, menopause and hormone replacement therapy. Post Reprod Health 24:11\u201318. https:\/\/doi.org\/10.1177\/2053369117731172","journal-title":"Post Reprod Health"},{"key":"2190_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5214\/ans.0972.7531.190403","volume":"19","author":"M Aggarwal","year":"2012","unstructured":"Aggarwal M, Puri V, Puri S (2012) Effects of estrogen on the serotoninergic system and calcitonin gene-related peptide in trigeminal ganglia of rats. Ann Neurosci 19:151\u2013157. https:\/\/doi.org\/10.5214\/ans.0972.7531.190403","journal-title":"Ann Neurosci"},{"key":"2190_CR32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/13697130902780846","volume":"12","author":"A Benshushan","year":"2009","unstructured":"Benshushan A, Rojansky N, Chaviv M, Arbel-Alon S, Benmeir A, Imbar T, Brzezinski A (2009) Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy. Climacteric 12:404\u2013409. https:\/\/doi.org\/10.1080\/13697130902780846","journal-title":"Climacteric"},{"key":"2190_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00042192-200007010-00005","volume":"7","author":"YA Wyon","year":"2000","unstructured":"Wyon YA, Spetz AC, Theodorsson GE, Hammar ML (2000) Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause 7:25\u201330. https:\/\/doi.org\/10.1097\/00042192-200007010-00005","journal-title":"Menopause"},{"key":"2190_CR34","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1590\/0004-282X20160153","volume":"74","author":"P Carturan","year":"2016","unstructured":"Carturan P, Scorcine C, Fragoso YD (2016) Migraine in the post-menopausal period is associated with higher levels of mood disorders, disability, and more menopausal symptoms. Arq Neuropsiquiatr 74:999\u20131002. https:\/\/doi.org\/10.1590\/0004-282X20160153","journal-title":"Arq Neuropsiquiatr"},{"key":"2190_CR35","doi-asserted-by":"publisher","first-page":"e2260","DOI":"10.1002\/brb3.2260","volume":"11","author":"C Baraldi","year":"2021","unstructured":"Baraldi C, Lo Castro F, Cainazzo MM, Pani L, Guerzoni S (2021) Predictors of response to erenumab after 12 months of treatment. Brain Behav 11:e2260. https:\/\/doi.org\/10.1002\/brb3.2260","journal-title":"Brain Behav"},{"key":"2190_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2147\/NDT.S285863","volume":"17","author":"R Ornello","year":"2021","unstructured":"Ornello R, Caponnetto V, Frattale I, Sacco S (2021) Patterns of migraine in postmenopausal women: a systematic review. Neuropsychiatr Dis Treat 17:859\u2013871. https:\/\/doi.org\/10.2147\/NDT.S285863","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2190_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/0333102419896760","volume":"40","author":"R Noseda","year":"2020","unstructured":"Noseda R, Schain AJ, Melo-Carrillo A, Tien J, Stratton J, Mai F, Strassman AM, Burstein R (2020) Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia 40:229\u2013240. https:\/\/doi.org\/10.1177\/0333102419896760","journal-title":"Cephalalgia"},{"key":"2190_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1526-4610.2011.01908.x","volume":"51","author":"S Gupta","year":"2011","unstructured":"Gupta S, McCarson KE, Welch KMA, Berman NEJ (2011) Mechanisms of pain modulation by sex hormones in migraine. Headache 51:905\u2013922. https:\/\/doi.org\/10.1111\/j.1526-4610.2011.01908.x","journal-title":"Headache"},{"key":"2190_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2014.08.002","volume":"346","author":"D Wang","year":"2014","unstructured":"Wang D, Zhao J, Wang J, Li J, Yu S, Guo X (2014) Deficiency of female sex hormones augments PGE2 and CGRP levels within midbrain periaqueductal gray. J Neurol Sci 346:107\u2013111. https:\/\/doi.org\/10.1016\/j.jns.2014.08.002","journal-title":"J Neurol Sci"},{"key":"2190_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1677\/joe.0.1750177","volume":"175","author":"M Noguchi","year":"2002","unstructured":"Noguchi M, Ikarashi Y, Yuzurihara M, Mizoguchi K, Kurauchi K, Chen JT, Ishige A (2002) Up-regulation of calcitonin gene-related peptide receptors underlying elevation of skin temperature in ovariectomized rats. J Endocrinol 175:177\u2013183. https:\/\/doi.org\/10.1677\/joe.0.1750177","journal-title":"J Endocrinol"},{"key":"2190_CR41","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s11095-017-2183-6","volume":"34","author":"T Vu","year":"2017","unstructured":"Vu T, Ma P, Chen JS, de Hoon J, Van Hecken A, Yan L, Wu LS, Hamilton L, Vargas G (2017) Pharmacokinetic-pharmacodynamic relationship of erenumab (AMG334) and capsaicin-induced dermal blood flow in healthy and migraine subjects. Pharm Res 34:1784\u20131795. https:\/\/doi.org\/10.1007\/s11095-017-2183-6","journal-title":"Pharm Res"},{"key":"2190_CR42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1177\/0333102421989601","volume":"41","author":"K Drellia","year":"2021","unstructured":"Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, Mitsikostas DD (2021) Anti-CGRP monoclonal antibodies for migraine prevention: a systematic review and likelihood to help or harm analysis. Cephalalgia 41:851\u2013864. https:\/\/doi.org\/10.1177\/0333102421989601","journal-title":"Cephalalgia"},{"key":"2190_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/164_2019_204","volume":"255","author":"E Rubio-Beltran","year":"2019","unstructured":"Rubio-Beltran E, Maassen van den Brink A (2019) Understanding CGRP and cardiovascular risk. Hand Exp Pharmacol 255:131\u2013140. https:\/\/doi.org\/10.1007\/164_2019_204","journal-title":"Hand Exp Pharmacol"},{"key":"2190_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/13697130601114917","volume":"10","author":"GMC Rosano","year":"2007","unstructured":"Rosano GMC, Vitale C, Marazzi G, Volterrani M (2007) Menopause and cardiovacsular disease: the evidence. Climacteric 10:19\u201324. https:\/\/doi.org\/10.1080\/13697130601114917","journal-title":"Climacteric"}],"updated-by":[{"DOI":"10.1007\/s13760-023-02340-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000}}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-023-02190-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T06:03:30Z","timestamp":1690092210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-023-02190-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2190"],"URL":"https:\/\/doi.org\/10.1007\/s13760-023-02190-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s13760-023-02340-9","asserted-by":"object"}]},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13760-023-02340-9","URL":"https:\/\/doi.org\/10.1007\/s13760-023-02340-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SG and CB received honoraria from Allergan Eli Lilly, Lundbeck, Novartis and Teva. BD has no conflict of interest to declare. MMC received honoraria from Allergan Eli Lilly and Lundbeck. FLC received honoraria from Allergan, Lundbeck and Novartis. LP has been a scientific consultant to Abbvie, USA; BCG, Switzerland; Boehringer-Ingelheim, Germany; Compass Pathways, UK; EDRA-Publishing, Italy; Johnson & Johnson, USA; Immunogen, USA; Inpeco, Switzerland; Nurosene, Canada; Relmada Therapeutics, USA; Takeda, USA; VeraSci, USA; Vifor, Switzerland; WCG-Clinical, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the Area Vasta Nord Ethics Committee (AVEN), with protocol number 625\/2020\/OSS\/AOUMO.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants signed informed consent for study participation and data publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants signed informed consent for data publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for data publication"}}]}}